Sample Page

• GAO Releases Report Urging Improved Efforts on Healthcare Price Transparency

  2 October 2024

• FDA Implements Reorganization Aimed to Enhance Collaboration

  1 October 2024

• MDMA Files Comments to FDA on Draft Guidance Regarding Diversity Action Plans

  26 September 2024

• FTC Files Lawsuits Against PBMs over Drug Pricing

  20 September 2024

• House Passes BIOSECURE Act

  9 September 2024

• MDMA Files Comments to CMS on CY 25 PFS and CY 25 OPPS/ASC Proposed Rules

  9 September 2024

• Federal Trade Commission’s Non-Compete Ban Blocked, Appeals Expected

  20 August 2024

• MDMA Statement on CMS’ Final TCET Notice and Guidance

  8 August 2024

• MDMA Responds to Request for Stakeholder Input on Next-Generation CURES Bill

  2 August 2024

• Shuren Departing CDRH, Dr. Michelle Tarver to Serve at Acting Director

  23 July 2024